What the Clinical Trials Show The most significant data so far comes from the TRIUMPH-1 trial, a Phase 3 study involving 2,339 adults with obesity or who were overweight
Research indicates that specific probiotic strains, including Lactobacillus , Bifidobacterium , and Enterobacter , may help ameliorate this inflammation (455)
Efficacy and safety of monotherapy with the novel sodium/glucose cotransporter-2 inhibitor Tofogliflozin in Japanese patients with type 2 diabetes mellitus: a combined phase 2 and 3 randomized, placebo-controlled, double-blind, parallel-group comparative study
Setting the Stage: Obesity and overweight conditions are not merely cosmetic concerns
Influenza B viruses do not have subtypes but are classified into two lineages: B/Yamagata and B/Victoria
Treatment Areas